Upregulation of the C/EBP β LAP isoform could be due to decreased TNFAIP3/TNIP1 expression in the peripheral blood mononuclear cells of patients with systemic lupus erythematosus

References

• Mok CC, Lau CS. Pathogenesis of systemic lupus erythematosus. J Clin Pathol. 2003;56:481–90.
   PubMed Web of Science ®Google Scholar
• Sang A, Zheng YY, Morel L. Contributions of B cells to lupus pathogenesis. Mol Immunol. 2014;62:329–38.
   PubMed Web of Science ®Google Scholar
• Hoffman RW. T cells in the pathogenesis of systemic lupus erythematosus. Clin Immunol. 2004;113:4–13.
   PubMed Web of Science ®Google Scholar
• Carroll MC. A protective role for innate immunity in systemic lupus erythematosus. Nat Rev Immunol. 2004;4:825–31.
   PubMed Web of Science ®Google Scholar
• Davis LS, Hutcheson J, Mohan C. The role of cytokines in the pathogenesis and treatment of systemic lupus erythematosus. J Interferon Cytokine Res. 2011;31:781–9.
   PubMed Web of Science ®Google Scholar
• Heyninck K, Beyaert R. A20 inhibits NF-kappaB activation by dual ubiquitin-editing functions. Trends Biochem Sci. 2005;30:1–4.
   PubMed Web of Science ®Google Scholar
• Mauro C, Pacifico F, Lavorgna A, Mellone S, Iannetti A, Acquaviva R, et al. ABIN-1 binds to NEMO/IKKgamma and co-operates with A20 in inhibiting NF-kappaB. J Biol Chem. 2006;281:18482–8.
   PubMed Web of Science ®Google Scholar
• Han JW, Zheng HF, Cui Y, Sun LD, Ye DQ, Hu Z, et al. Genome-wide association study in a Chinese Han population identifies nine new susceptibility loci for systemic lupus erythematosus. Nat Genet. 2009;41:1234–7.
   PubMed Web of Science ®Google Scholar
• Zhang DM, Cheng LQ, Zhai ZF, Feng L, Zhong BY, You Y, et al. Single-nucleotide polymorphism and haplotypes of TNIP1 associated with systemic lupus erythematosus in a Chinese Han population. J Rheumatol. 2013;40:1535–44.
   PubMed Web of Science ®Google Scholar
• Mele A, Cervantes J, Chien R, Friedman V, Ferran DC. Single nucleotide polymorphisms at the TNFAIP3/A20 locus and susceptibility/resistance to inflammatory and autoimmune diseases. Adv Exp Med Biol. 2014;809:163–83.
   PubMed Web of Science ®Google Scholar
• Li D, Wang L, Fan Y, Song L, Guo C, Zhu F, et al. Down-regulation of A20 mRNA expression in peripheral blood mononuclear cells from patients with systemic lupus erythematosus. J Clin Immunol. 2012;32:1287–91.
   PubMed Web of Science ®Google Scholar
• Sriskantharajah S, Ley SC. Cell biology. Turning off inflammation signaling. Science. 2010;327:1093–4.
   PubMed Web of Science ®Google Scholar
• Ramji DP, Foka P. CCAAT/enhancer-binding proteins: structure, function and regulation. Biochem J. 2002;365:561–75.
   PubMed Web of Science ®Google Scholar
• Sears RC, Sealy L. Multiple forms of C/EBP beta bind the EFII enhancer sequence in the Rous sarcoma virus long terminal repeat. Mol Cell Biol. 1994;14:4855–71.
   PubMed Web of Science ®Google Scholar
• Descombes P, Schibler U. A liver-enriched transcriptional activator protein, LAP, and a transcriptional inhibitory protein, LIP, are translated from the same mRNA. Cell. 1991;67:569–79.
   PubMed Web of Science ®Google Scholar
• Huber R, Pietsch D, Panterodt T, Brand K. Regulation of C/EBPβ and resulting functions in cells of the monocytic lineage . Cell Signal. 2012;24:1287–96.
   PubMed Web of Science ®Google Scholar
• Peng H, Wang W, Zhou M, Li R, Pan HF, Ye DQ. Role of interleukin-10 and interleukin-10 receptor in systemic lupus erythematosus. Clin Rheumatol. 2013;32:1255–66.
   PubMed Web of Science ®Google Scholar
• Yap DY, Lai KN. The role of cytokines in the pathogenesis of systemic lupus erythematosus—from bench to bedside. Nephrology (Carlton). 2013;18:243–55.
   PubMed Web of Science ®Google Scholar
• Fojtikova M, Cerna M, Pavelka K. [A review of the effects of prolactin hormone and cytokine on the development and pathogenesis of autoimmune diseases.] Vnitr Lek. 2010;56:402–13.
   PubMedGoogle Scholar
• Lai TY, Wu SD, Tsai MH, Chuang EY, Chuang LL, Hsu LC, Lai LC. Transcription of Tnfaip3 is regulated by NF-κB and p38 via C/EBPβ in activated macrophages. PLoS One. 2013;8:e73153.
   PubMed Web of Science ®Google Scholar
• Zhou J, Wu R, High AA, Slaughter CA, Finkelstein D, Rehg JE, et al. A20-binding inhibitor of NF-kappaB (ABIN1) controls Toll-like receptor-mediated CCAAT/enhancer-binding protein beta activation and protects from inflammatory disease. Proc Natl Acad Sci USA. 2011;108:E998–1006.
   PubMed Web of Science ®Google Scholar
• Chen Y, Yan H, Song Z, Chen F, Wang H, Niu J, et al. Downregulation of TNIP1 expression leads to increased proliferation of human keratinocytes and severer psoriasis-like conditions in an imiquimod-induced mouse model of dermatitis. PLoS One. 2015;10:e0127957.
   PubMed Web of Science ®Google Scholar
• Lane MD, Tang QQ, Jiang MS. Role of the CCAAT enhancer binding proteins (C/EBPs) in adipocyte differentiation. Biochem Biophys Res Commun. 1999;266:677–83.
   PubMed Web of Science ®Google Scholar
• Zahnow CA. CCAAT/enhancer-binding protein beta: its role in breast cancer and associations with receptor tyrosine kinases. Expert Rev Mol Med. 2009;11:e12.
   PubMed Web of Science ®Google Scholar
• Fausto N. Liver regeneration. J Hepatol. 2000;32:19–31.
   PubMed Web of Science ®Google Scholar
• Kishida T, Ejima A, Yamamoto K, Tanaka S, Yamamoto T, Mazda O. Reprogrammed functional brown adipocytes ameliorate insulin resistance and dyslipidemia in diet-induced obesity and type 2 diabetes. Stem Cell Reports. 2015;5:569–81.
   PubMed Web of Science ®Google Scholar
• Tengku-Muhammad TS, Hughes TR, Ranki H, Cryer A, Ramji DP. Differential regulation of macrophage CCAAT-enhancer binding protein isoforms by lipopolysaccharide and cytokines. Cytokine. 2000;12:1430–6.
   PubMed Web of Science ®Google Scholar
• Lyn-Cook BD, Xie C, Oates J, Treadwell E, Word B, Hammons G, Wiley K. Increased expression of Toll-like receptors (TLRs) 7 and 9 and other cytokines in systemic lupus erythematosus (SLE) patients: ethnic differences and potential new targets for therapeutic drugs. Mol Immunol. 2014;61:38–43.
   PubMed Web of Science ®Google Scholar
• Cigni A, Pileri PV, Faedda R, Gallo P, Sini A, Satta AE, et al. Interleukin 1, interleukin 6, interleukin 10, and tumor necrosis factor alpha in active and quiescent systemic lupus erythematosus. J Investig Med. 2014;62:825–9.
   PubMed Web of Science ®Google Scholar
• Shaabani N, Honke N, Dolff S, Gorg B, Khairnar V, Merches K, et al. IFN-γ licenses CD11b(+) cells to induce progression of systemic lupus erythematosus. J Autoimmun. 2015;62:11–21.
   PubMed Web of Science ®Google Scholar
• van der Krieken SE, Popeijus HE, Mensink RP, Plat J. CCAAT/enhancer binding protein β in relation to ER stress, inflammation, and metabolic disturbances. Biomed Res Int. 2015;2015:324815.
   PubMed Web of Science ®Google Scholar
• Koh JH, Lee J, Jung SM, Ju JH, Park SH, Kim HY, Kwok SK. Lupus cystitis in Korean patients with systemic lupus erythematosus: risk factors and clinical outcomes. Lupus. 2015;24:1300–7.
   PubMed Web of Science ®Google Scholar
• Fenton K. The effect of cell death in the initiation of lupus nephritis. Clin Exp Immunol. 2015;179:11–16.
   PubMed Web of Science ®Google Scholar
• Birmingham DJ, Irshaid F, Nagaraja HN, Zou X, Tsao BP, Wu H, et al. The complex nature of serum C3 and C4 as biomarkers of lupus renal flare. Lupus. 2010;19:1272–80.
   PubMed Web of Science ®Google Scholar
• Musone SL, Taylor KE, Lu TT, Nititham J, Ferreira RC, Ortmann W, et al. Multiple polymorphisms in the TNFAIP3 region are independently associated with systemic lupus erythematosus. Nat Genet. 2008;40:1062–4.
   PubMed Web of Science ®Google Scholar
• Liu J, Zhu L, Xie GL, Bao JF, Yu Q. Let-7 miRNAs modulate the activation of NF-κB by targeting TNFAIP3 and are involved in the pathogenesis of lupus nephritis. PLoS One. 2015;10:e0121256.
   PubMed Web of Science ®Google Scholar
• Kim SW, Ramasamy K, Bouamar H, Lin AP, Jiang D, Aguiar RC. MicroRNAs miR-125a and miR-125b constitutively activate the NF-kappaB pathway by targeting the tumor necrosis factor alpha-induced protein 3 (TNFAIP3, A20). Proc Natl Acad Sci USA. 2012;109:7865–70.
   PubMed Web of Science ®Google Scholar
• Horie R, Ishida T, Maruyama-Nagai M, Ito K, Watanabe M, Yoneyama A, et al. TRAF activation of C/EBPbeta (NF-IL6) via p38 MAPK induces HIV-1 gene expression in monocytes/macrophages. Microbes Infect. 2007;9:721–8.
   PubMed Web of Science ®Google Scholar
• Takeuchi O, Akira S. Pattern recognition receptors and inflammation. Cell. 2010;140:805–20.
   PubMed Web of Science ®Google Scholar
• Hunter C, Kadakia TB, Cooper D, Perretti M, Schwartz RC, Brown SB. Selective inhibitors of Kv11.1 regulate IL-6 expression by macrophages in response to TLR/IL-1R ligands. ScientificWorldJ. 2010;10:1580–96.
   PubMed Web of Science ®Google Scholar
• Aringer M, Smolen JS. TNF inhibition in SLE: where do we stand? Lupus. 2009;18:5–8.
   PubMed Web of Science ®Google Scholar
• Fries KL, Miller WE, Raab-Traub N. The A20 protein interacts with the Epstein-Barr virus latent membrane protein 1 (LMP1) and alters the LMP1/TRAF1/TRADD complex. Virology. 1999;264:159–66.
   PubMed Web of Science ®Google Scholar
• Studzinski GP, Wang X, Ji Y, Wang Q, Zhang Y, Kutner A, Harrison JS. The rationale for deltanoids in therapy for myeloid leukemia: role of KSR-MAPK-C/EBP pathway. J Steroid Biochem Mol Biol. 2005;97:47–55.
   PubMed Web of Science ®Google Scholar
• da Silva CG, Studer P, Skroch M, Mahiou J, Minussi DC, Peterson CR, et al. A20 promotes liver regeneration by decreasing SOCS3 expression to enhance IL-6/STAT3 proliferative signals. Hepatology. 2013;57:2014–25.
   PubMed Web of Science ®Google Scholar
• Zhang K, Guo W, Yang Y, Wu J. JAK2/STAT3 pathway is involved in the early stage of adipogenesis through regulating C/EBPβ transcription. J Cell Biochem. 2011;112:488–97.
   PubMed Web of Science ®Google Scholar